New Publication on Teduglutide in Pediatric Short Bowel Syndrome

A new publication on teduglutide appeared on September 17, 2026. The study, titled "Safety and long-term effectiveness of teduglutide in children with intestinal failure due to short bowel syndrome: a multicenter, post-marketing cohort study," was published in Pediatric Research. It is described as a multicenter, post-marketing cohort study focused on children with intestinal failure due to short bowel syndrome. The publication addresses teduglutide's safety and long-term effectiveness in this pediatric population. No specific findings or outcome data from the study have been provided beyond the publication's title and journal placement. Teduglutide remains an approved compound. Readers interested in the details of this study are encouraged to consult the full publication directly through the source listed. For general background on teduglutide, including its approved uses and mechanism, readers can consult the compound overview.